Skip to main content

Joint BSI-NCRI webinar – Cancer therapy: Pre-empting the future epidemic of immune-related adverse events

T-cells attacking cancer cells


We’re delighted to announce this joint virtual session with the National Cancer Research Institute (NCRI). Last year, we established a partnership with the NCRI to bring the immunology and cancer communities together to drive collaborations that address current challenges in immunotherapy through a series of joint initiatives, including this webinar.

This session will take place on Monday 19 October, 16:00 - 17:00 BST. It aims to raise awareness of immune-related adverse events in cancer treatment and to shed some light on the limited biological understanding of what’s causing them. It will offer a platform to allow cancer researchers and basic immunologists to come together to raise and address the open questions around immune-related adverse events and to better understand, predict, prevent and treat them.

This is a free session and it has been applied for 1 category 1 (external) CPD credit by the Federation of the Royal Colleges of Physicians.


  • Professor Bettina Ryll, Melanoma Patient Network Europe, Sweden
  • Dr Lucia Possamai, Imperial College London, UK
  • Professor Tomas Kirchhoff, NYU Grossman School of Medicine, USA

Chair: Professor Gary Middleton, University of Birmingham, UK

Registration is free! Find out more and register here.